Literature DB >> 230508

Identification of transferrin receptors on the surface of human cultured cells.

T A Hamilton, H G Wada, H H Sussman.   

Abstract

We have examined the binding of human transferrin to cultured human choriocarcinoma cell lines and to detergent extracts of such cells. The results indicate the presence of a high-affinity saturable binding site (Ka = 4.25 x 10(8) M-1) that is specific for transferrin. This receptor has also been detected on three other human cell lines of different phenotypic origin, including Wil-2 (splenic lymphocytes of B-cell origin), RPMI-2650 (a quasi-diploid nasopharyngeal carcinoma), and WI-38 (embryonic lung fibroblasts). By using anti-human transferrin antiserum to immunoprecipitate the receptor-transferrin complex from detergent extracts of cells containing saturating levels of transferrin followed by sodium dodecyl sulfate/polyacrylamide gel electrophoresis, a single polypeptide of 90,000 daltons has been identified as a subunit of the putative transferrin receptor. The protein shows immunochemical identity and coelectrophoreses in sodium dodecyl sulfate gels with a cell surface glycoprotein subunit, previously identified in placental brush border membrane preparations, on all human cultured cell lines examined. These results suggest that the recent demonstration of transferrin dependence of maximal cell growth in culture [e.g., Hutchings, S.E. & Sato, G.H. (1978) Proc. Natl. Acad. Sci. USA 75, 901-904] is mediated through expression of this glycoprotein receptor.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 230508      PMCID: PMC411873          DOI: 10.1073/pnas.76.12.6406

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Transferrin receptors on human B and T lymphoblastoid cell lines.

Authors:  J W Larrick; P Cresswell
Journal:  Biochim Biophys Acta       Date:  1979-04-03

2.  Growth and maintenance of HeLa cells in serum-free medium supplemented with hormones.

Authors:  S E Hutchings; G H Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

3.  Pituitary extracts and steroid hormones in the control of 3T3 cell growth.

Authors:  H A Armelin
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

4.  The establishment of a cell line of human hormone-synthesizing trophoblastic cells in vitro.

Authors:  R A Pattillo; G O Gey
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

5.  Thyroid hormone action: a cell-culture system responsive to physiological concentrations of thyroid hormones.

Authors:  H H Samuels; J S Tsai; R Cintron
Journal:  Science       Date:  1973-09-28       Impact factor: 47.728

6.  Replacement of serum by hormones permits growth of cells in a defined medium.

Authors:  I Hayashi; G H Sato
Journal:  Nature       Date:  1976-01-15       Impact factor: 49.962

7.  The growth stimulation of SV3T3 cells by transferrin and its dependence on biotin.

Authors:  D V Young; F W Cox; S Chipman; S C Hartman
Journal:  Exp Cell Res       Date:  1979-02       Impact factor: 3.905

8.  Localization of transferrin on the surface of the human placenta by electron microscopic immunocytochemistry.

Authors:  B F King
Journal:  Anat Rec       Date:  1976-10

9.  Identification of 125I-labeled rat reticulocyte membrane proteins with affinity for transferrin.

Authors:  A L Sullivan; L R Weintraub
Journal:  Blood       Date:  1978-08       Impact factor: 22.113

10.  The sialoglycoprotein subunits of human placental brush border membranes characterized by two-two-dimensional electrophoresis.

Authors:  H G Wada; Z Górnicki; H H Sussman
Journal:  J Supramol Struct       Date:  1977
View more
  41 in total

1.  A monoclonal antibody D51 recognizes the transferrin-receptor structure.

Authors:  H J Gross
Journal:  Blut       Date:  1985-08

2.  Modification of transplasma membrane oxidoreduction by SV40 transformation of 3T3 cells.

Authors:  H Löw; F L Crane; C Grebing; M Isaksson; A Lindgren; I L Sun
Journal:  J Bioenerg Biomembr       Date:  1991-12       Impact factor: 2.945

3.  Effects of different transferrin forms on transferrin receptor expression, iron uptake, and cellular proliferation of human leukemic HL60 cells. Mechanisms responsible for the specific cytotoxicity of transferrin-gallium.

Authors:  C R Chitambar; P A Seligman
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

4.  Iron transport kinetics through blood-brain barrier endothelial cells.

Authors:  Aminul Islam Khan; Jin Liu; Prashanta Dutta
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-02-18       Impact factor: 3.770

5.  The effect of desferrioxamine on transferrin receptors, the cell cycle and growth rates of human leukaemic cells.

Authors:  A Bomford; J Isaac; S Roberts; A Edwards; S Young; R Williams
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

6.  Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue.

Authors:  R Rossiello; M V Carriero; G G Giordano
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

Review 7.  Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.

Authors:  Stephanie Tortorella; Tom C Karagiannis
Journal:  J Membr Biol       Date:  2014-02-27       Impact factor: 1.843

8.  Transferrin receptors of human fibroblasts. Analysis of receptor properties and regulation.

Authors:  J H Ward; J P Kushner; J Kaplan
Journal:  Biochem J       Date:  1982-10-15       Impact factor: 3.857

9.  Membrane-bound lactoferrin alters the surface properties of polymorphonuclear leukocytes.

Authors:  L A Boxer; R A Haak; H H Yang; J B Wolach; J A Whitcomb; C J Butterick; R L Baehner
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

10.  Transferrin binding to peripheral blood lymphocytes activated by phytohemagglutinin involves a specific receptor. Ligand interaction.

Authors:  R M Galbraith; P Werner; P Arnaud; G M Galbraith
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.